Circulating AR copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer

In the present study, we aimed to evaluate the association of circulating AR copy number (CN) and outcome in a cohort of patients with advanced castration-resistant prostate cancer (CRPC) treated with enzalutamide after docetaxel. Fifty-nine CRPC patients were evaluated. AR CN was analyzed with real...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Salvi, Samanta, Casadio, Valentina, Conteduca, Vincenza, Lolli, Cristian, Gurioli, Giorgia, Martignano, Filippo, Schepisi, Giuseppe, Testoni, Sara, Scarpi, Emanuela, Amadori, Dino, Calistri, Daniele, Attard, Gerhardt, Giorgi, Ugo De
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2016
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5122353/
https://ncbi.nlm.nih.gov/pubmed/27191887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9341
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak